3 (-0.9 to 1.4); AMG 301 420 mg, 0.3 (-0.9 to 1.4). Lificiguat ic50 The incidence of adverse events was similar across groups.

AMG 301 offered no benefit over placebo for migraine prevention; further studies may be necessary to fully understand the role of PACAP isoforms and its receptors in migraine pathophysiology.…[Read more]